Chas McKhann
Chief Commercial Officer, Intersect ENT.
Companies
- Envoy Medical, Inc.Board member Apr 17, 2026 to now1
- Exagen Inc.Board member Mar 16, 2026 to now2
- Silk Road Medical IncBoard member Nov 3, 2023 to Sep 18, 20243
- Silk Road Medical IncChief executive officer Nov 3, 2023 to Sep 18, 20243
- Apollo Endosurgery (United States)Board member Mar 12, 2021 to Apr 4, 20234
- Apollo Endosurgery (United States)Chief executive officer Mar 12, 2021 to Apr 4, 20234
- Apollo Endosurgery (United States)President Mar 12, 2021 to Apr 4, 20234
- Intersect ENTChief Commercial Officer Feb 3, 2015 to Jan 20, 20165
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Exagen Inc. XGN7,500 shares6$64.4K at $8.59Apr 21, 2026
Apollo Endosurgery (United States)0 shares7Apr 4, 2023- Silk Road Medical Inc0 shares8Sep 17, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 17, 2024Returned to company 1,299,042 shares of Silk Road Medical Inc8
- Sep 17, 2024Granted 1,299,042 shares of Silk Road Medical Inc8
- Sep 17, 2024Returned to company 722,396 shares of Silk Road Medical Inc8
- Mar 1, 2024Granted 110,313 shares of Silk Road Medical Inc9
- Nov 2, 2023Granted 612,083 shares of Silk Road Medical Inc10
- Apr 4, 2023Returned to company 689,880 shares of Apollo Endosurgery (United States)7
- Jun 14, 2022Granted 112,607 shares of Apollo Endosurgery (United States)11
- May 5, 2022Shares withheld for tax 66,553 shares at $5.42 of Apollo Endosurgery (United States)12
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGAREnvoy Medical, Inc., Board member
- 2SEC EDGARExagen Inc., Board member
- 3SEC EDGARSilk Road Medical Inc, Board member
- 4
- 5
- 6
- 7
- 8
- 9SEC EDGARForm 4 filed Mar 5, 2024
- 10SEC EDGARForm 4 filed Nov 3, 2023
- 11SEC EDGARForm 4 filed Jun 16, 2022
- 12SEC EDGARForm 4 filed May 9, 2022